- At the clinic's price without markups
- with full doctor support
Kidney cancer is among the most common urological malignancies. In recent years, treatment approaches have changed significantly: instead of universal regimens, doctors now use personalized protocols based on the stage and specific characteristics of the tumor. Turkey has developed a strong school of uro-oncology, where surgeries, systemic therapy, and modern targeted treatments are performed according to international standards. According to Turkish multicenter studies, in localized stages, the 5-year survival rate after surgery reaches 94–97%, while for metastatic cases, modern combinations of surgery and immunotherapy extend patients’ average survival to 22–27 months (BMC Cancer, 2025). For international patients, this represents an opportunity to access high-quality medical care while receiving attentive, personalized support throughout their treatment journey.
Kidney Cancer Treatment and Survival Statistics in Turkey
When patients choose treatment abroad, they want to understand not only the level of equipment or the comfort of the clinic but also the real outcomes – survival rates, surgical effectiveness, and the performance of modern medications. In Turkey, there are large-scale studies that help assess the quality of care for kidney cancer.
Main Data on Metastatic Kidney Cancer
- In a multicenter study by the Turkish Oncology Group Kidney Cancer Consortium, patients with metastatic RCC who received sunitinib or pazopanib as first-line therapy followed by nivolumab had a median overall survival of 27.2 months (sunitinib) and 18.9 months (pazopanib) (BMC Cancer, 2025).
- When cytoreductive nephrectomy (removal of the kidney or part of the tumor) was added, median survival reached 22.7 months, compared to about 8.1 months without surgery (Current Oncology, 2024).
Survival After Surgery for Localized Stages
In a study involving 1,889 patients who underwent nephrectomy, the 5-year cancer-specific survival (CSS) rates were distributed by stage as follows:
- pT1a — ~97%
- pT1b — ~94%
- pT2a — ~88%
- pT2b — ~77%
- pT3a — ~74%
- pT4 — ~66%
(Journal of Urological Surgery, 2017)
Factors Influencing Prognosis
- The patient’s general condition according to the ECOG scale strongly affects survival
- Tumor size, lymph node involvement, and vascular invasion worsen the prognosis
- The type of surgery matters: at early stages, organ-preserving interventions (partial nephrectomy) can be performed, reducing body stress and speeding up recovery
What This Means for Patients
- At early stages, kidney cancer in Turkey is successfully treated surgically – the 5-year survival rate can reach 90–100%.
- In metastatic cases, the prognosis is poorer, but combining surgery with targeted and immunotherapy offers a real improvement in survival time.
- Turkish oncology centers actively follow international protocols (NCCN, ESMO), achieving results comparable to leading European clinics.
The cost of kidney cancer treatment in Turkey
Diagnostics
Before choosing a treatment protocol, the patient undergoes a comprehensive examination:
-
- Oncologist consultation – $150–350
- PET-CT – $650–1,100
- MRI of one area with contrast – $400–570
- Histology review – $200–500
-
Surgical Treatment
Surgery remains the main method of treatment for localized kidney cancer. In Turkey, both partial and radical nephrectomies are performed, including laparoscopic procedures or with the help of the Da Vinci robotic system.
- Bladder tumor removal – around $8,100
- Nephrectomy or kidney resection – the cost is calculated individually but usually ranges from $9,000 to $15,000, including hospitalization and postoperative care.
Systemic Therapy
Targeted drugs and immunotherapy are used for metastatic stages.
- Chemotherapy (1 course) – from $1,300
- Molecular therapy – $1,300–2,600
- Immunotherapy – $680–2,600
What Patients Should Keep in Mind
- At early stages, the main expenses are surgery and diagnostics.
- At later stages, a significant part of the budget goes to immunotherapy and targeted drugs.
Prices in Turkish clinics vary depending on the stage of the disease, the scope of surgery, and the chosen therapy plan. On average, treatment costs are lower than in Western Europe or Israel, while clinics follow international NCCN and ESMO standards. Below are approximate expenses most commonly encountered by patients diagnosed with kidney cancer.

At Experts Medical, we support patients at every stage – from the first inquiry to the full completion of treatment. Our services are free of charge: you pay only the medical bills directly to the clinic, with no commissions or extra fees. Everything we do is aimed at making treatment abroad clear, accessible, and effective.
What we do for you
- We analyze your situation and select the best options for clinics and doctors.
- We receive specific treatment plans from oncologists with precise prices and timelines.
- We help you understand which procedures are truly necessary and which can be avoided.
- We organize your trip: transfer, accommodation, appointment scheduling, and visa assistance if necessary.
- We accompany you on site and after treatment, and always stay in touch.
Why It’s Convenient to Work with Us
- You don't pay us - only directly to the clinic.
- The price remains the same as when contacting the clinic directly, and sometimes even lower.
- We protect your interests by ensuring that all agreements are fulfilled.
- Always in touch - a coordinator will respond to you via messenger, and a supervising physician will help you understand the details of your treatment.
- We have 9 years of experience and our own list of verified doctors and clinics.
We always act transparently – you know in advance what to expect. We never impose unnecessary procedures and do not work with clinics we do not trust. Our goal is to make treatment abroad feel simple and not intimidating.
How to start treatment with Experts Medical: step-by-step and stress-free
- Contact us and have an initial consultation.
Our medical coordinator will answer all your questions and explain where to start. The consultation is free and held in your native language – this is important to help you feel comfortable and confident.
- Prepare medical documents.
We will ask you to send any medical reports, test results, and conclusions you already have. If something is missing, we will advise you where to quickly complete the necessary examinations.
- Submit documents to the clinics and wait for responses.
We will send your medical documents to several Turkish clinics, where leading oncologists and uro-oncologists will review them. The doctors will prepare a preliminary treatment plan and estimate the cost of therapy.
- Get a treatment plan and make a decision.
You will receive a clear document outlining which procedures or surgeries are recommended, how long the treatment will take, and how much it will cost. If the condition remains stable, the final plan will match the initial estimate. You can also schedule an online consultation with the chosen doctor.
How long does the treatment take?
The duration of therapy depends on the stage of the disease, chosen methods, and the patient’s overall condition. To make it easier to understand, below are the approximate timeframes for the main stages of kidney cancer treatment in Turkey.
- Diagnostics. Usually takes about five days. During this time, the patient undergoes laboratory tests, specialist consultations, and imaging studies such as MRI, CT, or PET-CT. After the examinations are completed, a medical board meets to determine the optimal treatment strategy together.
- Chemotherapy. One treatment cycle lasts about a month. The patient remains under medical supervision during therapy, and if their condition is stable, they can return home and continue taking medications according to the prescribed schedule. Follow-up checkups are usually scheduled every two to three months and can be done locally or sent for remote evaluation.
- Radiation therapy. A radiotherapy course usually consists of thirty daily sessions without breaks and takes about five weeks. This schedule allows gradual impact on the tumor while minimizing stress on healthy tissues.
- Genetic tests for targeted therapy. The analysis process takes about two weeks. Once the results are ready, the doctor selects a personalized treatment plan. To avoid wasting time during this waiting period, supportive therapy may be prescribed.
- Surgical treatment. If only surgery is required, staying in Turkey usually takes about seven to ten days. This period includes preoperative preparation, the operation itself, and the early recovery phase under the supervision of surgeons.
Conclusion
Treating kidney cancer requires precision at every stage, from diagnosis to surgery and systemic therapy. In Turkey, there are teams that not only follow international protocols but also deliver real, measurable results. Robotic surgeries, targeted therapies, multidisciplinary boards, and personalized treatment plans are all part of the approach, even in complex cases.
We work only with clinics and doctors we know personally and whose results we have seen in practice. This allows us to offer patients not just a list of options, but concrete solutions that have already helped others. And if you’re just starting this journey – contact us. We’ll help you figure out where to begin, what steps to take next, and how to go through this process with full support.
Frequently Asked Questions
1. Is it possible to undergo molecular tumor profiling to select targeted therapy?
Yes, several Turkish centers perform genetic sequencing and mutation analysis, including VHL, MET, PBRM1, and others. This is especially important when planning treatment for metastatic kidney cancer.
2. Are kidney-sparing surgeries performed in Turkey for small and medium-sized tumors?
Yes, organ-preserving resection is prioritized for tumors up to 4 cm (T1a) and in some cases up to 7 cm (T1b). Such surgeries are most often performed laparoscopically or using the Da Vinci robotic system.
3. Which targeted and immunotherapy drugs are available in Turkish clinics?
Internationally approved drugs are available, including sunitinib, pazopanib, cabozantinib, nivolumab, ipilimumab, as well as combinations of immuno-onco-targeted therapies. The choice depends on the stage, prognostic group, and prior treatments.
4. Can Turkish clinics accept patients after unsuccessful treatment in another country?
Yes, we regularly assist patients who have already undergone treatment, including those who experienced complications, disease progression, or ineffective regimens. Doctors review previous protocols, conduct additional diagnostics, and offer an alternative plan.


















